Workflow
Amgen(AMGN) - 2025 Q3 - Earnings Call Transcript

Amgen (NasdaqGS:AMGN) Q3 2025 Earnings Call November 04, 2025 04:30 PM ET Company ParticipantsMurdo Gordon - EVP of Global Commercial OperationsRobert Bradway - CEOSalveen Richter - Managing Director of Global Investment ResearchTerence Flynn - Managing DirectorEvan Seigerman - Managing DirectorCasey Capparelli - VP of Investor RelationsJames Bradner - EVP of Research and DevelopmentChris Schott - Managing DirectorPeter Griffith - CFOConference Call ParticipantsMatthew Phipps - Group Head of Biotech Equity ...